OrbiMed’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
|
|||||
2024
Q2 | $2.15M | Sell |
|
|||||
2024
Q1 | $112M | Sell |
|
|||||
2023
Q4 | $152M | Sell |
|
|||||
2023
Q3 | $143M | Hold |
|
|||||
2023
Q2 | $140M | Hold |
|
|||||
2023
Q1 | $157M | Hold |
|
|||||
2022
Q4 | $167M | Sell |
|
|||||
2022
Q3 | $146K | Buy |
|
|||||
2022
Q2 | $141K | Buy |
|
|||||
2022
Q1 | $127M | Buy |
|
|||||
2021
Q4 | $76.1M | Buy |
|
|||||
2021
Q3 | $8.57M | Buy |
|
|||||
2020
Q2 | – | Sell |
|
|||||
2020
Q1 | $45.7M | Buy |
|
|||||
2019
Q4 | $2.93M | Buy |
|
|||||
2019
Q3 | – | Sell |
|
|||||
2019
Q2 | $6.42M | Sell |
|
|||||
2019
Q1 | $6.79M | Hold |
|
|||||
2018
Q4 | $6.51M | Hold |
|
|||||
2018
Q3 | $7.42M | Hold |
|
|||||
2018
Q2 | $7.21M | Sell |
|
|||||
2018
Q1 | $11.8M | Buy |
|
|||||
2017
Q4 | $8.97M | Sell |
|
|||||
2017
Q3 | $69.2M | Sell |
|
|||||
2017
Q2 | $89.2M | Sell |
|
|||||
2017
Q1 | $112M | Hold |
|
|||||
2016
Q4 | $106M | Buy |
|
|||||
2016
Q3 | $107M | Sell |
|
|||||
2016
Q2 | $118M | Buy |
|
|||||
2016
Q1 | $84.4M | Buy |
|
|||||
2015
Q4 | $15.6M | Sell |
|
|||||
2015
Q3 | $19.8M | Hold |
|
|||||
2015
Q2 | $25.7M | Buy |
|
|||||
2014
Q3 | – | Sell |
|
|||||
2014
Q2 | $89.3M | Sell |
|
|||||
2014
Q1 | $102M | Buy |
|
|||||
2013
Q4 | $99.5M | Sell |
|
|||||
2013
Q3 | $114M | Buy |
|
|||||
2013
Q2 | $74.8M | Buy |
|